Ticker: BBIO

Company: BridgeBio Pharma, Inc.

Person: Andrew Lo, director

Transaction date: Nov. 17, 2025

Reporting date: Nov. 19, 2025

Average share price: 66.10594704756326

Sold 95599.0 shares for 6319662.43